Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Sodium chloride 0.9% and potassium chloride 0.3% in plastic container provides isotonic crystalloid solution for resuscitation and maintenance of extracellular fluid volume. Sodium chloride restores sodium and chloride deficits, while potassium chloride replenishes potassium, essential for maintaining cellular membrane potential, nerve conduction, and muscle contraction, including cardiac function.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion, rate and volume determined by clinical need: typical adult dose is 1-2 L/day for maintenance or replacement, up to 3-4 L/day for deficits; maximum infusion rate 1 L/hour under continuous monitoring. Contains 0.9% sodium chloride (154 mEq/L Na+, Cl-) and 0.3% potassium chloride (40 mEq/L K+).
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Sodium and chloride: 6–12 hours (tissue distribution equilibrium); potassium: 12–24 hours (slow exchange from intracellular stores). Clinical context: half-life prolonged in renal impairment.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >95% as chloride and sodium ions; potassium ions also excreted renally (90% reabsorbed, remainder excreted). Biliary/fecal: negligible (<5%).
Category C
Category A/B
Electrolyte
Electrolyte